Rivasi Giulia, Capacci Marco, Del Re Lorenzo Maria, Ambrosino Ilaria, Ceolin Ludovica, Liccardo Alessandra, Bisignano Maria Francesca, D'Ambrosio Giuseppe, Ceccarelli Greta, Matteucci Giulia, Mossello Enrico, Ungar Andrea
Division of Geriatric and Intensive Care Medicine, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.
Drugs Aging. 2025 Apr;42(4):373-380. doi: 10.1007/s40266-025-01196-3. Epub 2025 Mar 11.
In older adults, trazodone is frequently prescribed for anxiety and insomnia owing to its perceived greater tolerability in comparison with benzodiazepines. However, it may have hypotensive effects.
The aim of this study is to investigate the effects of trazodone on orthostatic blood pressure (BP) response and risk of syncope and falls in hypertensive older adults.
A longitudinal observational study involving patients ≥ 75 years was conducted in two geriatric outpatient clinics in Florence, Italy. At baseline, participants underwent a 3-min active stand test, office BP measurement and home and ambulatory BP monitoring. At follow-up, syncope and falls were recorded.
Among 123 participants (mean age 81 years, 59% female), 12 (10%) reported regular trazodone use. Trazodone users showed lower office diastolic BP (71.8 versus 80.1 mmHg, p = 0.042), a greater systolic and diastolic BP reduction immediately after standing (Δsystolic 23.8 versus 14.3 mmHg, p = 0.037; Δdiastolic 8.9 versus 1.6 mmHg, p = 0.004) and a greater diastolic BP reduction after 1-min standing (Δdiastolic 6.5 versus 0 mmHg, p = 0.029). No differences were reported for home or ambulatory BP. Incidence of syncope and falls was 25%, with a significantly higher rate in patients receiving trazodone (58.3% versus 21.2%, p = 0.001). Trazodone use predicted syncope and falls independently of age, disability and fall history. This association was not confirmed when adjusting for dementia diagnosis. BP values were not associated with the study outcome.
In older hypertensive outpatients, trazodone is associated with a greater orthostatic BP drop and may predispose them to an increased risk of syncope and falls.
在老年人中,由于与苯二氮䓬类药物相比,曲唑酮被认为耐受性更好,因此常用于治疗焦虑和失眠。然而,它可能有降压作用。
本研究旨在调查曲唑酮对老年高血压患者直立性血压(BP)反应以及晕厥和跌倒风险的影响。
在意大利佛罗伦萨的两家老年门诊进行了一项针对≥75岁患者的纵向观察性研究。在基线时,参与者接受3分钟主动站立试验、诊室血压测量以及家庭和动态血压监测。在随访时,记录晕厥和跌倒情况。
在123名参与者(平均年龄81岁,59%为女性)中,12人(10%)报告经常使用曲唑酮。使用曲唑酮的患者诊室舒张压较低(71.8对80.1 mmHg,p = 0.042),站立后即刻收缩压和舒张压下降幅度更大(收缩压下降23.8对14.3 mmHg,p = 0.037;舒张压下降8.9对1.6 mmHg,p = 0.004),站立1分钟后舒张压下降幅度更大(舒张压下降6.5对0 mmHg,p = 0.029)。家庭或动态血压未见差异。晕厥和跌倒发生率为25%,接受曲唑酮治疗的患者发生率显著更高(58.3%对21.2%,p = 0.001)。使用曲唑酮可独立于年龄、残疾和跌倒史预测晕厥和跌倒。调整痴呆诊断后,这种关联未得到证实。血压值与研究结果无关。
在老年高血压门诊患者中,曲唑酮与更大的直立性血压下降相关,可能使他们发生晕厥和跌倒的风险增加。